Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Research & Development (2023 - 2025)

Historic Research & Development for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $5.4 million.

  • Profound Medical's Research & Development rose 3005.28% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 2843.23%. This contributed to the annual value of $17.0 million for FY2024, which is 1761.65% up from last year.
  • Profound Medical's Research & Development amounted to $5.4 million in Q3 2025, which was up 3005.28% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Profound Medical's Research & Development registered a high of $6.1 million during Q2 2025, and its lowest value of $3.2 million during Q2 2023.
  • In the last 3 years, Profound Medical's Research & Development had a median value of $4.2 million in 2024 and averaged $4.3 million.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 273.44% in 2024, then soared by 4501.78% in 2025.
  • Quarter analysis of 3 years shows Profound Medical's Research & Development stood at $4.0 million in 2023, then rose by 15.82% to $4.6 million in 2024, then increased by 16.54% to $5.4 million in 2025.
  • Its Research & Development was $5.4 million in Q3 2025, compared to $6.1 million in Q2 2025 and $4.8 million in Q1 2025.